Mark Zafereo

机构：Texas Medical Center, The University of Texas MD Anderson Cancer Center · ORCID：0000-0001-7918-9739

发表论文 344 篇 · 总被引 10081 次 · h-index 55

代表论文

Real-World Experience with Lenvatinib plus Pembrolizumab in Metastatic BRAF Wild-Type Anaplastic Thyroid Carcinoma (2026 · Thyroid · 被引 5)
The American Thyroid Association Multidisciplinary Consensus Statement on Ambulatory Thyroid Surgery (2026 · Thyroid · 被引 2)
The shifting landscape of germline RET pathogenic variants with the introduction of panel testing (2025 · Surgery · 被引 2)
Lenvatinib plus pembrolizumab for the treatment of patients with non-BRAF mutated anaplastic thyroid cancer: A single center, phase 2 clinical trial (2026 · European Journal of Cancer · 被引 1)
TRAPPC4 Promotes GPX4 Stability to Drive Ferroptosis Resistance and Tumor Progression in Head and Neck Squamous Cell Carcinoma (2026 · Cancer Research · 被引 1)
Deceptive Thyroid Pathologies: Anaplastic Thyroid Carcinoma Mimics and Clinical Implications (2026 · Head & Neck · 被引 1)